Previous Article | Next Article ![]()
Applied and Environmental Microbiology, September 2001, p. 4335-4337, Vol. 67, No. 9
School of Biological Sciences, University of Liverpool,
Liverpool, L69 7ZB,1 Gut Microbiology
and Immunology Division, Rowett Research Institute, Bucksburn,
Aberdeen AB21 9SB,2 and The Centre for
Applied Microbiological Research, Porton Down,
Salisbury,3 United Kingdom
Received 12 March 2001/Accepted 18 June 2001
A verocytotoxigenic bacteriophage isolated from a strain of
enterohemorrhagic Escherichia coli O157, into which a
kanamycin resistance gene (aph3) had been inserted to
inactivate the verocytotoxin gene (vt2), was
used to infect Enterobacteriaceae strains. A number of
Shigella and E. coli strains were susceptible
to lysogenic infection, and a smooth E. coli isolate (O107)
was also susceptible to lytic infection. The lysogenized strains
included different smooth E. coli serotypes of both human
and animal origin, indicating that this bacteriophage has a substantial
capacity to disseminate verocytotoxin genes. A novel indirect plaque
assay utilizing an E. coli recA441 mutant in which
phage-infected cells can enter only the lytic cycle, enabling detection
of all infective phage, was developed.
Verocytotoxigenic Escherichia
coli (VTEC) is a serious pathogen of considerable public health
concern worldwide. Infection is usually characterized by bloody
diarrhea and can be life threatening due to the subsequent development
of hemolytic-uremic syndrome mediated by verocytotoxins (VTs), of which
there are two forms, VT1 and VT2. In almost all cases, the VT genes are
carried on temperate bacteriophages (VT phages). Although E. coli O157 is the most commonly isolated VTEC serogroup in the
United Kingdom, North America, and Japan, more than 30 disease-causing
non-0157 VTECs have been described (1) and over 100 serotypes are capable of producing VT (6). VT production
has been observed in other members of the
Enterobacteriaceae, including Enterobacter
cloacae (8) and Citrobacter freundii
(12), but was first described in Shigella
dysenteriae as Shiga toxin (3). The localization of
vt genes on a bacteriophage was first described by Smith et al. (13), but their acquisition by pathogenic E. coli strains remained anomalous because only nonpathogenic (rough)
E. coli strains could apparently be infected with VT phage.
Previously, the vt2 gene of a bacteriophage
( The host range of this recombinant VT2 phage
( As it is clear that some phage infections create lysogens and do not
result in a lytic infection, plaque assays may not necessarily detect
all infectious phage particles. Induction of the VT phage lytic cycle
is RecA dependent (7). RecA plays a central role in the
SOS response of E. coli, during which phage-mediated lysis is induced. The recA441 mutant E. coli K-12
strain, DM1187 (5), was used to detect all free phage
particles. This mutation results in constitutive activation of RecA
protease in the absence of induction. This leads to inactivation of the
phage immunity repressor, preventing maintenance of lysogeny and
forcing the phage into the lytic cycle. Phage stocks were prepared in
this strain and stored at 4°C. Strain DM1187-rif was created by
successive passage in increasing rifampin concentrations (5 to 500 µg
ml A range of E. coli strains from ruminants, pigs, and humans
and a number of representatives of other enteric bacterial genera were
screened for susceptibility to lysis and/or lysogeny by
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.9.4335-4337.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Lytic and Lysogenic Infection of Diverse
Escherichia coli and Shigella Strains with a
Verocytotoxigenic Bacteriophage
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
24B), isolated from an E. coli O157 strain,
had been inactivated by insertion of a selectable marker (kanamycin
resistance) (10). This provided an ideal opportunity to
investigate the host range of a lysogenic VT bacteriophage and thus its
potential to transfer the ability to produce VT between E. coli and related gram-negative bacteria.
24B::Kan) was determined by infection of
pathogenic and commensal strains of E. coli and other
Enterobacteriaceae strains from human and animal sources.
Lysogens were detected by spreading phage-infected cultures of the host
bacteria (100 µl) onto Luria-Bertani Miller (LB) agar (Difco) plates
containing kanamycin (50 µg ml
1).
1). An indirect plaque assay was developed using this
DM1187-rif strain, enabling the detection of all free infectious phage
particles in any infection mix. Briefly, DM1187-rif was added, as an
indicator, to a culture previously infected with phage. Rifampin (300 µg ml
1) was incorporated in the soft agar overlay to
select for the indicator host. Lysogens from this infection mix, which
could not be of DM1187 origin, could be detected on LB agar (Difco) containing kanamycin (50 µg ml
1). This allowed the
detection of all free infective particles. Strain MC1061, an E. coli K-12 strain possessing wild type RecA, was susceptible to
both lysis and lysogeny and was used as a control throughout.
24B::Kan. The strain groups and sources are
listed in Table 1 along with the
proportion of susceptible strains in each group. All of the wild-type
strains were shown to be vt2-negative by
application of the PCR protocol described below for confirming lysogens
after
24B::Kan infection. Primers VT2A3'
(5'-TCTGTTCAGAAACGCTGC-3') and VT2A5'
(5'-TACTGTGCCTGTTACTGG-3') were designed from the published sequence of the 933W VT2 phage (GenBank accession number NC_000924) (9) to amplify the vt2A subunit
gene. All
24B::Kan-susceptible strains were
shown to be sensitive to kanamycin (50 µg ml
1) and
lacked detectable norfloxacin or UV-inducible prophages.
TABLE 1.
Susceptibility of Enterobacteriaceae hosts to
infection with bacteriophage
24B::Kan
To test the ability of
24B::Kan to infect
wild-type strains, cultures were grown in LB broth containing 0.01 M
CaCl2 to mid-exponential phase (optical density at 600 nm,
ca. 0.5). Phage suspensions were added to a final concentration of
107 PFU ml
1. Infection mixtures were
incubated at 37°C with shaking at 120 rpm. Duplicate samples (100 µl) were taken after 2 h and spread on LB agar containing 50 µg of kanamycin ml
1 and incubated overnight at 37°C
to select for putative lysogens. Control infections in which
bacteriophage was omitted were conducted in parallel to confirm that
kanamycin resistance was dependent on phage infection. Susceptibility
of the strains to lytic infection by
24B::Kan
was determined by conventional plaque assay.
Of the total 113 strains tested, 30 of the 103 E. coli
strains and all 4 of the Shigella strains were susceptible
to lysogenic infection by
24B::Kan, indicated
by growth in the presence of kanamycin after infection. In all cases,
lysogens were confirmed by detection of the inactivated
vt2A subunit gene
(vt2A::aph3) in the
kanamycin-resistant colonies by PCR amplification. The primers VT2A3'
and VT2A5' were used to amplify the
vt2A::aph3 gene from
bacterial colonies and genomic DNA preparations from putative lysogens,
to yield a 2.2-kb product in all cases. The Taq polymerase
(MBI Fermentas) system was used according to the manufacturer's
instructions in the presence of 1.5 mM MgCl2. Cycling conditions were comprised of a 94°C denaturation step (4 min), a
56°C annealing step (30 s), and a 72°C extension step (2 min 45 s) for 35 cycles with the GenAmp PCR System 2400 (Perkin-Elmer). PCR products were visualized by gel electrophoresis
(0.75% agarose containing 0.4 µg of ethidium bromide
ml
1).
Lysogens were induced to release infective phage particles by exposing
mid-exponential-phase cultures of representative kanamycin-resistant colonies to norfloxacin (1 µg ml
1) (Sigma)
(4) for 1 h or to UV light (256 nm) for 40 s.
Induced cultures were allowed to recover by subculture (1 ml) in fresh LB broth containing CaCl2 (0.01 M) (2 h). Released phage
particles were detected by the indirect plaque assay with DM1187-rif
described above. These data are summarized in Table 1.
E. coli strains from both animal and human sources were susceptible to lysogenic infection by the phage, and this included a large number of strains isolated from the rumen. The other strains of Enterobacteriaceae species studied were not susceptible to the phage, with the exception of the Shigella sonnei and Shigella flexneri strains, whose susceptibility was not unexpected in view of their relationships to VTEC (2). Of the seven E. coli K-12 strains tested, six were susceptible to both lysogenic and lytic infection; the expected exception was strain DM1187, which is the RecA mutant susceptible only to lytic infection.
The precise sources and serotypes of the wild-type strains susceptible
to
24B::Kan are shown in Table
2. The most important feature of these
data is the range of E. coli serotypes represented, including smooth strains with intact lipopolysaccharide. It has been
suggested previously that VT phages can infect only rough strains of
E. coli and S. sonnei (13),
inferring that the phage receptor(s) is masked by lipopolysaccharide O
side chains. This can now be refuted, since a smooth strain, F172, was
susceptible to lytic infection (Table 2). Although the rough E. coli K-12 strains were very susceptible to both lysis and lysogeny
by this VT phage, one smooth strain (serotype O107) was equally
susceptible to both. Schmidt et al. (11) studied the host
range of a different VT phage using a chloramphenicol resistance gene
insert to inactivate vt and also found that VT genes could
potentially be disseminated to different E. coli strains.
However, their study examined only human isolates and a limited range
of serotypes. The overwhelming preference for lysogeny rather than
lysis among susceptible E. coli isolates is, nevertheless, a
feature of both the data reported here and those of Schmidt and
coworkers (11), with the exception of strain F172.
|
VT phage host range is an important indicator of the potential for vt gene transfer in clinical and agricultural environments. The VT phage used here exhibited a broad host range among E. coli and Shigella isolates, but susceptibility, i.e., the number of lysogens generated within 2 h, varied between strains (data not shown). This is evident because an enrichment step was not used following phage infection. While the reasons for this are not clear, it suggests that lysogen formation, and not just production of an observable plaque, is an important indicator of infectivity and should be an integral part of future studies on the epidemiology of temperate bacteriophages. The recA441 mutation carried by E. coli DM1187 provides a convenient tool to enable the detection of every infective particle of such lambdoid phages, including those that would otherwise be destined for lysogeny.
| |
ACKNOWLEDGMENTS |
|---|
This work was funded by the Ministry of Agriculture Fisheries and Food, the Biotechnology and Biological Sciences Research Council, and the Scottish Executive Rural Affairs Department, Edinburgh, United Kingdom.
We thank C. A. Hart of the Department of Medical Microbiology, University of Liverpool, for supplying clinical isolates and T. Cheasty of PHLS, Colindale, United Kingdom, for serotyping the susceptible strains.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: School of Biological Sciences, Life Sciences Building, University of Liverpool, Crown Street, Liverpool L69 7ZB, United Kingdom. Phone: 44-151-794-4413. Fax: 44-151-794-4401. E-mail: aj55m{at}liverpool.ac.uk.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Acheson, D. W.,
J. Reidl,
X. Zhang,
G. T. Keusch,
J. J. Mekalanos, and M. K. Waldor.
1998.
In vivo transduction with Shiga toxin 1-encoding phage.
Infect. Immun.
66:4496-4498 |
| 2. | Johnson, J. R. 2000. Shigella and Escherichia coli at the crossroads: machiavellian masquerades or taxonomic treachery? J. Med. Microbiol. 49:583-585[Medline]. |
| 3. | Keusch, G. T. 1998. The rediscovery of Shiga toxin and its role in clinical disease. Jpn. J. Med. Sci. Biol. 51:S5-S22. |
| 4. |
Matsushiro, A.,
K. Sato,
H. Miyamoto,
T. Yamamura, and T. Honda.
1999.
Induction of prophages of enterohemorrhagic Escherichia coli O157:H7 with norfloxacin.
J. Bacteriol.
181:2257-2260 |
| 5. |
Mount, D. W.
1977.
A mutant of Escherichia coli showing constitutive expression of the lysogenic induction and error-prone DNA repair pathways.
Proc. Natl. Acad. Sci. USA
74:300-304 |
| 6. |
Nataro, J. P., and J. B. Kaper.
1998.
Diarrheagenic Escherichia coli.
Clin. Microbiol. Rev.
11:142-201 |
| 7. | Neely, M. N., and D. I. Friedman. 1998. Functional and genetic analysis of regulatory regions of coliphage H-19B: location of Shiga-like toxin and lysis genes suggest a role for phage function in toxin release. Mol. Microbiol. 28:1255-1267[CrossRef][Medline]. |
| 8. | Paton, A. W., and J. C. Paton. 1996. Enterobacter cloacae producing a Shiga-like toxin II-related cytotoxin associated with a case of hemolytic-uremic syndrome. J. Clin. Microbiol. 34:463-465[Abstract]. |
| 9. |
Plunkett, G., III,
D. J. Rose,
T. J. Durfee, and F. R. Blattner.
1999.
Sequence of Shiga toxin 2 phage 933W from Escherichia coli O157:H7: Shiga toxin as a phage late-gene product.
J. Bacteriol.
181:1767-1778 |
| 10. | Saunders, J. R., M. J. Sergeant, A. J. McCarthy, K. J. Mobbs, C. A. Hart, T. S. Marks, and R. J. Sharp. 1999. Genetics and molecular ecology of Escherichia coli O157, p. 1-25. In C. S. Stewart, and H. J. Flint (ed.), Escherichia coli O157 in farm animals. CABI Publishing, Wallingford, Oxon, United Kingdom. |
| 11. |
Schmidt, H.,
M. Bielaszewska, and H. Karch.
1999.
Transduction of enteric Escherichia coli isolates with a derivative of Shiga toxin 2-encoding bacteriophage 3538 isolated from Escherichia coli O157:H7.
Appl. Environ. Microbiol.
65:3855-3861 |
| 12. |
Schmidt, H.,
M. Montag,
J. Bockemühl,
J. Heesemann, and H. Karch.
1993.
Shiga-like toxin II-related cytotoxins in Citrobacter freundii strains from humans and beef samples.
Infect. Immun.
61:534-543 |
| 13. | Smith, H. W., P. Green, and Z. Parsell. 1983. Vero cell toxins in Escherichia coli and related bacteria: transfer by phage and conjugation and toxic action in laboratory animals, chickens and pigs. J. Gen. Microbiol. 129:3121-3137[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Microbiol. Mol. Biol. Rev. | Eukaryot. Cell | All ASM Journals |
|---|